US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 0.829
  • -0.041-4.71%
Close Jul 19 16:00 ET
  • 0.870
  • +0.041+4.95%
Post 18:00 ET
6.02MMarket Cap0.01P/E (TTM)

About Transcode Therapeutics Company

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

Company Profile

SymbolRNAZ
Company NameTranscode Therapeutics
Listing DateJul 9, 2021
Issue Price4.00
Founded2016
CEOMr. Thomas A. Fitzgerald, M.B.A.
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6 Liberty Square,Suite 2382
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02109
Phone1-857-837-3099

Company Executives

  • Name
  • Position
  • Salary
  • Thomas A. Fitzgerald, M.B.A.
  • Interim President, Chief Executive Officer, Director, Vice President, Chief Financial Officer and Principal Accounting Officer
  • 426.86K
  • Dr. Zdravka Medarova
  • Chief Scientific Officer
  • --
  • Dr. Philippe P. Calais, PhD
  • Executive Chairman of the Board
  • 112.61K
  • Dr. Erik Manting, PhD
  • Independent Director
  • 73.11K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 75.11K
  • Dr. Anna Moore, PhD
  • Scientific Advisor
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg